Review

Published on 05 Oct 2022

The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: A meta-analysis of published prospective studies

in Drugs Outcomes Research and Policies

Fuxun Zhang
Yang Xiong
Wei Wang
Changjing Wu
Feng Qin
Jiuhong Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.973394

1,503 views
1 citation

Original Research

Published on 05 Oct 2022

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking

in Drugs Outcomes Research and Policies

Xinbo Yang
Xianrong Xing
Yirui Liu
Yuanjie Zheng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.962863

2,150 views
1 citation

Original Research

Published on 05 Oct 2022

Impact of the expert consensus on polypharmacy and potentially inappropriate medication use in elderly lung cancer outpatients with multimorbidity: An interrupted time series analysis, 2016–2021

in Drugs Outcomes Research and Policies

Fangyuan Tian
Zhaoyan Chen
Rui Tang
Qiyi Feng
Fengbo Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.992394

1,215 views
1 citation

Original Research

Published on 04 Oct 2022

Fasting plasma glucose and HbA1c levels predict the risk of type 2 diabetes and diabetic retinopathy in a Thai high-risk population with prediabetes

in Drugs Outcomes Research and Policies

Chaiwat Washirasaksiri
Weerachai Srivanichakorn
Nutsakol Borrisut
Tullaya Sitasuwan
Rungsima Tinmanee
Chayanis Kositamongkol
Pinyapat Ariyakunaphan
Chonticha Auesomwang
Naruemit Sayabovorn
Thanet Chaisathaphol

Frontiers in Pharmacology

doi 10.3389/fphar.2022.950225

2,260 views
1 citation

Original Research

Published on 03 Oct 2022

Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study

in Drugs Outcomes Research and Policies

Nuria Carballo
Carolina Pérez García
Santiago Grau
Jordi Monfort
Xavier Durán-Jordà
Daniel Echeverría-Esnal
Olivia Ferrández

Frontiers in Pharmacology

doi 10.3389/fphar.2022.980832

1,734 views
1 citation

Review

Published on 03 Oct 2022

Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues

in Drugs Outcomes Research and Policies

Bibhuti Bhusan Kakoti
Rajashri Bezbaruah
Nasima Ahmed

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1007315

3,935 views
4 citations

Original Research

Published on 03 Oct 2022

Adverse reaction signals mining and hemorrhagic signals comparison of ticagrelor and clopidogrel: A pharmacovigilance study based on FAERS

in Drugs Outcomes Research and Policies

Shu Tang
Zhanshen Wu
Liqing Xu
Qiang Wen
Xiaojian Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.970066

2,479 views
3 citations

Original Research

Published on 30 Sep 2022

Potentially inappropriate medications in older Chinese outpatients based on the Beers criteria and Chinese criteria

in Drugs Outcomes Research and Policies

Ying Zhang
Zhaoyan Chen
Fangyuan Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2022.991087

1,325 views
1 citation

Original Research

Published on 30 Sep 2022

Real-world use of orphan medicinal products (OMPs) in rare disease (RD) patients: A population-based registry study

in Drugs Outcomes Research and Policies

Monica Mazzucato
Cinzia Minichiello
Andrea Vianello
Laura Visonà dalla Pozza
Ema Toto
Paola Facchin

Frontiers in Pharmacology

doi 10.3389/fphar.2022.940010

2,063 views

Systematic Review

Published on 30 Sep 2022

Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials

in Drugs Outcomes Research and Policies

Yaowang Lin
Zhigang Cai
Shaohong Dong
Huadong Liu
Xinli Pang
Qiuling Chen
Jie Yuan
Qingshan Geng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.992376

2,581 views
1 citation

Systematic Review

Published on 30 Sep 2022

Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis

in Drugs Outcomes Research and Policies

Xudong Guan
Shengzhao Zhang
Jiayan Liu
Fengbo Wu
Lingyan Zhou
Ying Liu
Na Su

Frontiers in Pharmacology

doi 10.3389/fphar.2022.998441

4,218 views

Original Research

Published on 30 Sep 2022

Cost-effectiveness analysis of lenvatinib plus pembrolizumab compared with chemotherapy for patients with previously treated mismatch repair proficient advanced endometrial cancer in China

in Drugs Outcomes Research and Policies

Zhiwei Zheng
Liu Yang
Siqi Xu
Huide Zhu
Hongfu Cai

Frontiers in Pharmacology

doi 10.3389/fphar.2022.944931

2,550 views
4 citations

Original Research

Published on 29 Sep 2022

Pharmacists’ experiences on adverse drug reaction: 10 years later

in Drugs Outcomes Research and Policies

Mahmathi Karuppannan
Nur Azzrin Nisha Mohamad Rizal
Kok-Thong Wong
Salmiah Mohd. Ali
Kang-Nee Ting
Helen Boardman

Frontiers in Pharmacology

doi 10.3389/fphar.2022.932942

2,248 views
1 citation

Systematic Review

Published on 29 Sep 2022

Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysis

in Drugs Outcomes Research and Policies

Mingye Zhao
Taihang Shao
Yinan Ren
Caicun Zhou
Wenxi Tang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.910656

5,497 views

Systematic Review

Published on 29 Sep 2022

Evidence basis for using dexmedetomidine to enhance the quality of paravertebral block: A systematic review and meta-analysis of randomized controlled trials

in Drugs Outcomes Research and Policies

Rong Tang
Yu-Qian Liu
Hai-Lian Zhong
Fang Wu
Shi-Xiong Gao
Wei Liu
Wen-Sheng Lu
Ying-Bin Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.952441

1,219 views
1 citation

Editorial

Published on 28 Sep 2022

Editorial: Prevention, diagnosis and treatment of rare disorders

in Drugs Outcomes Research and Policies

Timothy M. Cox
Anna Tylki-Szymańska
Ségolène Aymé
Marc Dooms

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1026064

1,248 views

Navigation group

Articles

The efficacy and safety of intralesional injection of collagenase Clostridium histolyticum for Peyronie’s disease: A meta-analysis of published prospective studies

Screening of potential inhibitors targeting the main protease structure of SARS-CoV-2 via molecular docking

Impact of the expert consensus on polypharmacy and potentially inappropriate medication use in elderly lung cancer outpatients with multimorbidity: An interrupted time series analysis, 2016–2021

Fasting plasma glucose and HbA1c levels predict the risk of type 2 diabetes and diabetic retinopathy in a Thai high-risk population with prediabetes

Real-world effectiveness and persistence of reference etanercept versus biosimilar etanercept GP2015 among rheumatoid arthritis patients: A cohort study

Therapeutic drug repositioning with special emphasis on neurodegenerative diseases: Threats and issues

Adverse reaction signals mining and hemorrhagic signals comparison of ticagrelor and clopidogrel: A pharmacovigilance study based on FAERS

Potentially inappropriate medications in older Chinese outpatients based on the Beers criteria and Chinese criteria

Real-world use of orphan medicinal products (OMPs) in rare disease (RD) patients: A population-based registry study

Comparative efficacy and safety of antiplatelet or anticoagulant therapy in patients with chronic coronary syndromes after percutaneous coronary intervention: A network meta-analysis of randomized controlled trials

Cardiovascular safety of febuxostat and allopurinol in patients with gout: A meta-analysis

Cost-effectiveness analysis of lenvatinib plus pembrolizumab compared with chemotherapy for patients with previously treated mismatch repair proficient advanced endometrial cancer in China

Pharmacists’ experiences on adverse drug reaction: 10 years later

Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysis

Evidence basis for using dexmedetomidine to enhance the quality of paravertebral block: A systematic review and meta-analysis of randomized controlled trials

Editorial: Prevention, diagnosis and treatment of rare disorders